by Robin Foster In the highest tally ever recorded for tuberculosis cases, the World Health Organization report that over 8 million people worldwide were diagnosed with the lung disease last year. Of that number, 1.25 million people died of TB, the new report found, meaning that it is once again the leading cause of deaths from infectious...
Tag: <span>Tuberculosis (TB)</span>
Post
Study finds tuberculosis changes liver metabolism and could promote diabetes
Scientists from the University of Leicester have discovered that tuberculosis disrupts glucose metabolism in the body University of Leicester Professor Andrea Cooper from the University of Leicester Credit: University of Leicester Scientists from the University of Leicester have discovered that tuberculosis disrupts glucose metabolism in the body. The findings, which have now been published in PLoS...
Post
How an AI solution can design new tuberculosis drug regimens
by Jim Lynch, University of Michigan Credit: CC0 Public Domain With a shortage of new tuberculosis drugs in the pipeline, a software tool from the University of Michigan can predict how current drugs—including unlikely candidates—can be combined in new ways to create more effective treatments. “This could replace our traditional trial-and-error system for drug development that is comparatively...
Post
Tuberculous infection is not life-long in most people
Penn-led study suggested majority will not develop disease even if test shows positive results UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE PHILADELPHIA – A new analysis challenges the longstanding notion that tuberculous infection is a life-long infection that could strike at any time and cause tuberculosis (TB). Based on a review of clinical studies, researchers from...
Post
A Simple Regimen Can Prevent TB. Why Aren’t More People on It?
Two antibiotics, taken for a month, can stop a leading killer. But “when it’s for TB, people just sort of shrug.” Tuberculosis struck 10 million people worldwide in 2017, killing 1.6 million of them — a toll greater than that of H.I.V., malaria, measles and Ebola combined. TB is the leading infectious killer around the...
Post
FDA approves TB pill that cures more hard-to treat patients
by Linda A. Johnson U.S. regulators Wednesday approved a new tuberculosis medicine that shortens and improves treatment for the hardest-to-treat cases, a worsening problem in many poor countries. It’s the first TB drug from a nonprofit group. The TB Alliance, formed to come up with better treatments, developed pretomanid with help from charities and government...
Post
Standard TB tests may not detect infection in certain exposed individuals
Study published in Nature Medicine UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER CLEVELAND – An international collaboration of infectious disease experts has identified a large group of people who appear to have naturally mounted an immune response to TB, a bacterial infection that is the leading cause of infectious disease death worldwide. Nearly 200 people from 2500 households with active TB were...
Post
TB doesn’t only attack the lungs—other organs are also vulnerable
The world marks World Tuberculosis (TB) Day on March 24 every year. Most people assume that TB only affects the lungs – but the disease can also attack other organs. The Conversation Africa’s Ina Skosana spoke to Professor Nazir Ismail to find out more. Professor Ismail works and conducts his research in South Africa, one of the world’s TB hot spots. What parts of the body does TB affect? TB most...
Post
South Asians at risk for tuberculosis often are not tested
Many South Asian immigrants from countries where tuberculosis (TB) is common do not get tested even though they are at high risk for developing the disease, according to a recent study by Rutgers University and St. Peter’s University Hospital. Scanning electron micrograph of Mycobacterium tuberculosis bacteria, which cause TB. Credit: NIAID Tuberculosis, which mainly affects...
Post
Temperature-stable experimental tuberculosis vaccine enters clinical testing
Vaccinations have begun in a Phase 1 human clinical trial testing a freeze-dried, temperature-stable formulation of an experimental tuberculosis (TB) vaccine candidate. The trial is being conducted at the Saint Louis University School of Medicine Center for Vaccine Development and will enroll as many as 48 healthy adult volunteers aged 18 to 55 years. The...
- 1
- 2